Results
24,511 records
Include
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 8 | Murphy Andrew JCo-Chief Scientific Officer |  REGNREGENERON PHARMACEUTICALS, INC.Open-market sale · 10b5-1 plan | SELL | $173K 224 sh |
Every ingested record across SEC Form 4, 13F, House PTRs and Robinhood Chain, searchable by ticker, name or wallet address.
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 8 | Murphy Andrew JCo-Chief Scientific Officer | REGNREGENERON PHARMACEUTICALS, INC. Open-market sale · 10b5-1 plan | SELL | $173K 224 sh |
| Oct 15, 2026 traded Oct 14, 2026 |
| 8 | Murphy Andrew JCo-Chief Scientific Officer | REGNREGENERON PHARMACEUTICALS, INC. Open-market sale · 10b5-1 plan | SELL | $98K 127 sh | Oct 15, 2026 traded Oct 14, 2026 |
| 8 | Murphy Andrew JCo-Chief Scientific Officer | REGNREGENERON PHARMACEUTICALS, INC. Open-market sale · 10b5-1 plan | SELL | $51K 66 sh | Oct 15, 2026 traded Oct 14, 2026 |
| 8 | Murphy Andrew JCo-Chief Scientific Officer | REGNREGENERON PHARMACEUTICALS, INC. Open-market sale · 10b5-1 plan | SELL | $218K 283 sh | Oct 15, 2026 traded Oct 14, 2026 |
| 8 | Murphy Andrew JCo-Chief Scientific Officer | REGNREGENERON PHARMACEUTICALS, INC. Open-market sale · 10b5-1 plan | SELL | $207K 271 sh | Oct 15, 2026 traded Oct 14, 2026 |
| 8 | Murphy Andrew JCo-Chief Scientific Officer | REGNREGENERON PHARMACEUTICALS, INC. Open-market sale · 10b5-1 plan | SELL | $167K 219 sh | Oct 15, 2026 traded Oct 14, 2026 |
| 8 | Murphy Andrew JCo-Chief Scientific Officer | REGNREGENERON PHARMACEUTICALS, INC. Open-market sale · 10b5-1 plan | SELL | $214K 279 sh | Oct 15, 2026 traded Oct 14, 2026 |
| 8 | Murphy Andrew JCo-Chief Scientific Officer | REGNREGENERON PHARMACEUTICALS, INC. Open-market sale · 10b5-1 plan | SELL | $94K 121 sh | Oct 15, 2026 traded Oct 14, 2026 |
| 8 | Murphy Andrew JCo-Chief Scientific Officer | REGNREGENERON PHARMACEUTICALS, INC. Open-market sale · 10b5-1 plan | SELL | $56K 74 sh | Oct 15, 2026 traded Oct 14, 2026 |
| 8 | Murphy Andrew JCo-Chief Scientific Officer | REGNREGENERON PHARMACEUTICALS, INC. Open-market sale · 10b5-1 plan | SELL | $147K 192 sh | Oct 15, 2026 traded Oct 14, 2026 |
| 8 | Murphy Andrew JCo-Chief Scientific Officer | REGNREGENERON PHARMACEUTICALS, INC. Open-market sale · 10b5-1 plan | SELL | $81K 105 sh | Oct 15, 2026 traded Oct 14, 2026 |
| 7 | Eddy Robert W.Director, President & CEO |  BJBJ's Wholesale Club Holdings, Inc.Open-market sale · 10b5-1 plan | SELL | $517K 5,000 sh | Oct 15, 2026 traded Oct 15, 2026 |
| 6 |  Kurtz GeorgeDirector, PRESIDENT AND CEO |  CRWDCrowdStrike Holdings, Inc.Open-market sale · 10b5-1 plan | SELL | $156K 600 sh | Oct 15, 2026 traded Oct 13, 2026 |
| 6 | Kurtz GeorgeDirector, PRESIDENT AND CEO | CRWDCrowdStrike Holdings, Inc. Open-market sale · 10b5-1 plan | SELL | $220K 883 sh | Oct 15, 2026 traded Oct 14, 2026 |
| 6 | Kurtz GeorgeDirector, PRESIDENT AND CEO | CRWDCrowdStrike Holdings, Inc. Open-market sale · 10b5-1 plan | SELL | $54K 200 sh | Oct 15, 2026 traded Oct 13, 2026 |
| 6 | Kurtz GeorgeDirector, PRESIDENT AND CEO | CRWDCrowdStrike Holdings, Inc. Open-market sale · 10b5-1 plan | SELL | $126K 476 sh | Oct 15, 2026 traded Oct 13, 2026 |
| 6 | Kurtz GeorgeDirector, PRESIDENT AND CEO | CRWDCrowdStrike Holdings, Inc. Open-market sale · 10b5-1 plan | SELL | $171K 640 sh | Oct 15, 2026 traded Oct 13, 2026 |
| 5 | Murphy Andrew JCo-Chief Scientific Officer | REGNREGENERON PHARMACEUTICALS, INC. Open-market sale · 10b5-1 plan | SELL | $18K 24 sh | Oct 15, 2026 traded Oct 14, 2026 |
| 5 | Murphy Andrew JCo-Chief Scientific Officer | REGNREGENERON PHARMACEUTICALS, INC. Open-market sale · 10b5-1 plan | SELL | $9,242 12 sh | Oct 15, 2026 traded Oct 14, 2026 |
| 5 | Murphy Andrew JCo-Chief Scientific Officer | REGNREGENERON PHARMACEUTICALS, INC. Open-market sale · 10b5-1 plan | SELL | $42K 55 sh | Oct 15, 2026 traded Oct 14, 2026 |
| 5 | Murphy Andrew JCo-Chief Scientific Officer | REGNREGENERON PHARMACEUTICALS, INC. Open-market sale · 10b5-1 plan | SELL | $30K 38 sh | Oct 15, 2026 traded Oct 14, 2026 |
| 5 | Murphy Andrew JCo-Chief Scientific Officer | REGNREGENERON PHARMACEUTICALS, INC. Open-market sale · 10b5-1 plan | SELL | $26K 35 sh | Oct 15, 2026 traded Oct 14, 2026 |
| 5 | Murphy Andrew JCo-Chief Scientific Officer | REGNREGENERON PHARMACEUTICALS, INC. Open-market sale · 10b5-1 plan | SELL | $12K 16 sh | Oct 15, 2026 traded Oct 14, 2026 |
| 5 | Murphy Andrew JCo-Chief Scientific Officer | REGNREGENERON PHARMACEUTICALS, INC. Open-market sale · 10b5-1 plan | SELL | $19K 25 sh | Oct 15, 2026 traded Oct 14, 2026 |
| 5 | Murphy Andrew JCo-Chief Scientific Officer | REGNREGENERON PHARMACEUTICALS, INC. Open-market sale · 10b5-1 plan | SELL | $39K 50 sh | Oct 15, 2026 traded Oct 14, 2026 |
| 5 | Murphy Andrew JCo-Chief Scientific Officer | REGNREGENERON PHARMACEUTICALS, INC. Open-market sale · 10b5-1 plan | SELL | $4,523 6 sh | Oct 15, 2026 traded Oct 14, 2026 |
| 5 | Murphy Andrew JCo-Chief Scientific Officer | REGNREGENERON PHARMACEUTICALS, INC. Open-market sale · 10b5-1 plan | SELL | $21K 27 sh | Oct 15, 2026 traded Oct 14, 2026 |
| 5 | Murphy Andrew JCo-Chief Scientific Officer | REGNREGENERON PHARMACEUTICALS, INC. Open-market sale · 10b5-1 plan | SELL | $11K 14 sh | Oct 15, 2026 traded Oct 14, 2026 |
| 4 | Boughton SoleilChief Legal Officer |  HIMSHims & Hers Health, Inc.Open-market sale · 10b5-1 plan | SELL | $101K 3,461 sh | Oct 15, 2026 traded Oct 14, 2026 |
| 4 |  Huffman Steve LaddDirector, CEO & President, 10% Owner |  RDDTReddit, Inc.Open-market sale · 10b5-1 plan | SELL | $529K 3,408 sh | Oct 15, 2026 traded Oct 13, 2026 |
| 4 | Kumaraswami RaviPres. Worldwide Field Ops. |  RSKDRISKIFIED LTD.Open-market sale · 10b5-1 plan | SELL | $543K 65.0K sh | Oct 15, 2026 traded Oct 15, 2026 |
| 4 | Huffman Steve LaddDirector, CEO & President, 10% Owner | RDDTReddit, Inc. Open-market sale · 10b5-1 plan | SELL | $290K 1,800 sh | Oct 15, 2026 traded Oct 13, 2026 |
| 4 | Huffman Steve LaddDirector, CEO & President, 10% Owner | RDDTReddit, Inc. Open-market sale · 10b5-1 plan | SELL | $397K 2,500 sh | Oct 15, 2026 traded Oct 13, 2026 |
| 4 | Huffman Steve LaddDirector, CEO & President, 10% Owner | RDDTReddit, Inc. Open-market sale · 10b5-1 plan | SELL | $662K 4,200 sh | Oct 15, 2026 traded Oct 13, 2026 |
| 4 | Eddy Robert W.Director, President & CEO | BJBJ's Wholesale Club Holdings, Inc. Open-market sale · 10b5-1 plan | SELL | $209K 2,000 sh | Oct 15, 2026 traded Oct 15, 2026 |
| 4 | Eddy Robert W.Director, President & CEO | BJBJ's Wholesale Club Holdings, Inc. Open-market sale · 10b5-1 plan | SELL | $105K 1,000 sh | Oct 15, 2026 traded Oct 15, 2026 |
| 4 | Huffman Steve LaddDirector, CEO & President, 10% Owner | RDDTReddit, Inc. Open-market sale · 10b5-1 plan | SELL | $275K 1,700 sh | Oct 15, 2026 traded Oct 13, 2026 |
| 3 | Kurtz GeorgeDirector, PRESIDENT AND CEO | CRWDCrowdStrike Holdings, Inc. Open-market sale · 10b5-1 plan | SELL | $41K 160 sh | Oct 15, 2026 traded Oct 14, 2026 |
| 1 |  Robinhood Markets, Inc.10% Owner |  RVIRobinhood Ventures Fund IOpen-market sale · 10b5-1 plan | SELL | $114K 4,537 sh | Oct 15, 2026 traded Oct 14, 2026 |
| 1 | Robinhood Markets, Inc.10% Owner | RVIRobinhood Ventures Fund I Open-market sale · 10b5-1 plan | SELL | $110K 4,362 sh | Oct 15, 2026 traded Oct 13, 2026 |